Drug intelligence / Profile preview

rhus toxicodendron

Development stage
Phase 2
Lead developer
Healthcare Homoeo Charitable Society
Administration
Oral, Sublingual, Topical
01

Overview

Rhus toxicodendron is a homeopathic medicine derived from the fresh leaves of the poison ivy plant (*Toxicodendron radicans*). It is a cornerstone of homeopathic materia medica, primarily utilized for the treatment of musculoskeletal conditions such as rheumatoid arthritis, osteoarthritis, and sprains, as well as skin conditions like shingles and eczema. The preparation involves serial dilution and succussion according to homeopathic pharmacopoeia standards, typically to potencies such as 30C or 200C, where the original plant molecules are virtually absent. Clinical research, including studies sponsored by the Healthcare Homoeo Charitable Society, has evaluated its safety and efficacy in reducing joint pain and inflammation in patients with rheumatoid arthritis. While its mechanism is not defined by conventional molecular pharmacology, it is traditionally indicated for symptoms that are aggravated by initial movement or cold, damp weather but improved by continued motion.

Brand names
Rhus Tox
Other names
Poison ivyToxicodendron radicansRhus toxicodendron 30Rhus tox
02

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on rhus toxicodendron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhus toxicodendron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call